Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) is a critical regulatory segment of the CASP3 transcript that governs the expression of the executioner caspase-3 protein (UniProt P42574). This region contains multiple binding sites for microRNAs (miRNAs) and RNA-binding proteins, which collectively modulate mRNA stability and translation efficiency (NCBI Gene ID: 836). In many cancers, overexpression of oncogenic miRNAs like miR-21 targets this 3'UTR to suppress Caspase-3 production, thereby facilitating apoptosis evasion and chemoresistance (Zhu et al., 2008, Cell Research; PMID: 18443608). Conversely, in neurodegenerative conditions or acute injuries like stroke, the dysregulation of this region can lead to pathological overexpression of Caspase-3, driving excessive cell death (PubMed: 21471066). Therapeutic strategies targeting the CASP3 mRNA 3'UTR include the use of antisense oligonucleotides (ASOs) or miRNA mimics to either restore or inhibit Caspase-3 levels depending on the disease context (NCBI PMC: PMC3921586). While promising, these approaches face challenges such as ensuring tissue-specific delivery and minimizing off-target effects on other mRNA transcripts that share similar regulatory sequences (Nature Reviews Drug Discovery, 2020).
Modulation of mRNA stability and translation efficiency through competitive binding or RNA interference (RNAi) at the 3' untranslated region to control Caspase-3 protein levels.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase-3 messenger RNA 3' untranslated region (CASP3 mRNA 3'UTR) (CASP3 mRNA 3'UTR).